<unk>  is a combination of an anticholinergic and a long-acting beta2-adrenergic agonist that is FDA approved for the treatment of of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nasopharyngitis, cough, and back pain.
Tiotropium bromide and olodaterol
Lumacaftor and ivacaftor
Glycopyrrolate and formoterol fumarate
Indacaterol and glycopyrrolate
Netupitant and palonosetron
Cetirizine hydrochloride
Tezacaftor / ivacaftor
Fluticasone/salmeterol